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Abstract
Background Intraosseous (IO) access is an alternative to
conventional intravenous access.
Aims We evaluate the use of the EZ-IO™ as an alternative
vascular access for patients in the emergency department.
Methods A non-randomized, prospective, observational
study was performed in adults using the EZ-IO™ powered
drill device.
Results Twenty-four patients were recruited. There were 35
intraosseous insertions, including 24 tibial and 11 humeral
insertions. All EZ-IO™ insertions were achieved within 20 s
and were successful at the first attempt except for one. Of the
intraosseous insertions, 88.6% were reported to be easier
than intravenous cannulation. We found flow rates to be
significantly faster using a pressure bag. The seniority of
operators did not affect the success of insertion. Complica-
tions included a glove being caught in the drill device and
extravasation of fluid although they were easily preventable.
Conclusion The use of the EZ-IO™ provides a fast, easy
and reliable alternative mode of venous access, especially
in the resuscitation of patients with no venous vascular
access in the emergency department. Flow rates may be
improved by the use of pressure bags.
Keywords Intraosseousneedle.Intravenous access.
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Introduction
The intraosseous (IO) route for vascular access was initially
described in 1922 [1] and was used commonly during
World War II [2]. Although the intravascular route is the
standard for venous access in medical practice, IO ad-
ministration of fluids and medications can be an alternative
option when the conventional method of intravenous access
fails.
Drugs administered intraosseously enter the circulation
as fast and in the same concentration as those administered
intravenously [3, 4]. However, there have not been any
published clinical trials assessing the use of the EZ-IO™ in
the busy emergency department (ED) of a tertiary hospital
setting although there have been studies on the paediatric
population [3–11].
Intraosseous access has recently been revived in adults as
an alternative when conventional intravenous access may be
difficult or impossible [3, 12–15]. The standard IO needle
has been compared with needles having a newer design and
most recently with IO access devices [3, 11, 12, 16–19]. The
EZ-IO™ is one such device for adult IO vascular access.
We carried out a non-randomized, prospective, observa-
tional study evaluating the use of the EZ-IO™ powered drill
deviceforIOaccessinadultspresentingtoa local tertiaryED.
Methods
We conducted a non-randomized, prospective, observation-
al study in adults using the EZ-IO™ powered drill device.
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Waiver of consent was obtained as the procedures were
deemed to be life saving in the critically ill requiring
peripheral access that would not have otherwise been
obtained by traditional methods quickly. If the patient was
awake enough to understand, verbal and if possible written
informed consent was obtained from the patient.
The study population included patients who presented to
the Department of Emergency Medicine of Singapore
General Hospital (SGH), an urban hospital that is Singa-
pore’s oldest and largest acute tertiary hospital and national
referral centre.
The SGH Department of Emergency Medicine handles
nearly 120,000 patients annually, of which about 9%
are resuscitations (priority 1), 33% are major emergen-
cies (priority 2), 56% are ambulant/minor emergencies
(priority 3) and 2% are non-emergencies (priority 4).
Inclusion criteria were patients who presented to the ED
with age greater than 16 years or>40 kg body weight
requiring intravenous fluids or medications and in whom an
intravenous line could not be established in two attempts or
90 s. They also had to be seriously ill or injured and possess
one or more of the following:
1. An altered mental state [score on the Glasgow Coma
Scale (GCS) of 8 or less]
2. Respiratory compromise [oxygen saturation (SaO2)
80% after appropriate oxygen therapy, respiratory rate
<10 or >40/min]
3. Haemodynamic instability [systolic blood pressure
(BP) of <90] or profound hypovolaemia (signs and
symptoms of shock)
4. Cardiac arrest (medical or traumatic)
Insertion of an IO needle was contraindicated if there
was a fracture of the tibia or femur, recent surgery in the
extremity to be used or previous orthopaedic procedure
(knee replacement) or IO within 24 h (consider alternate
tibia), pre-existing medical condition (tumour near insertion
site or peripheral vascular disease), infection at insertion
site or significant oedema in the extremity to be used. The
use of the alternate tibia would be considered in those
scenarios. Inability to locate landmarks, significant oedema
and excessive tissue at insertion site were relative contra-
indications to insertion.
The EZ-IO™ utilizes a reusable battery-powered driver
and a disposable IO needle set that powers into the IO
space by rotating a hollow drill to a preset depth (EZ-IO™
System Driver model number 9050, PD needle set model
9018, AD needle set model 9001, Vidacare Corporation,
San Antonio, TX, USA).
Sites of insertion included the tibia and the humerus. The
landmark for the insertion point of the proximal tibia is 2
fingerbreadths below the patella and 1–2 cm medial to the
tibial tuberosity. The landmark for the insertion point for
the proximal humerus is the most prominent aspect of the
greater tubercle’s outer margins, with the patient’s hand on
his abdomen to ensure the safest position. A pressure bag
device would be applied to the infusion if its rate of
infusion was deemed to be too slow.
The outcomes that were assessed included the success
rate of EZ-IO™ insertion by operators as defined by the
ability to place the IO needle, as well successfully infusing
fluids and drugs. Flow rates using normal saline infusion
were measured by an independent nurse observer. Methods
of IO needle placement confirmation, estimated total time
of insertion, fluids and drugs administered, ease of use and
the control and function of the EZ-IO™ device, any
complications, difficulties in using the device, adverse
events to operator and types of malfunction of device were
evaluated by a questionnaire.
Placement time was recorded by the individual operator,
recorded as the time the operator placed the needle set into
the driver till the time the needle was successfully inserted
into the bone. The difficulty of insertion was recorded by
the physicians on a 10-cm visual analogue scale (VAS) with
0 representing very easy placement and 10 representing
very difficult placement.
Only emergency physicians and medical residents who
were trained in the use of the EZ-IO™ by completing the
manufacturer’s training programme and who were familiar
with the protocol were allowed to use the device. Standard
training for IO insertion was straightforward and lasted less
than 2 h. This consisted of a lecture and hands-on training
[20, 21]. The physicians were given instructions on the use
of the EZ-IO™ and observed a demonstration on its use on
a standard plastic bone model of the tibia as provided for by
the manufacturer. The physicians were subsequently
allowed multiple practices to obtain IO access using the
EZ-IO™ on the plastic bone model.
During the actual IO placement, needle placement was
confirmed by visualization of blood on the stylet, ability to
aspirate bone marrow, firm placement of the needle in the
bone and ability to smoothly deliver a fluid flush. Operators
were instructed to give a rapid flush (bolus) of 10 ml of saline
with a syringe through the EZ-IO™ once needle placement
was confirmed.For conscious patients, a prior flush (bolus) of
20–50 mg 2% lidocaine (preservative free) through the EZ-
IO™ was recommended for local anaesthesia.
Patients were followed up until hospital discharge for
any complications of IO insertion, including needle
displacement, failure of the drill device to function
properly, fractures, infection of the insertion site, osteomy-
elitis, fat embolism, extravasation of fluid or medication
and compartment syndrome.
DatawereenteredusingMicrosoftExcel2002(version10)
and data analysis was performed using SPSS Statistics 15.0.
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categorical comparisons and the Mann-Whitney U test for
equivalent non-parametric comparisons.
Results
From 1 March 2006 to 30 July 2007, 24 patients were
recruited. The tibia was the first site of insertion, and a
second IO was inserted in the humerus if clinically
indicated for the same patient. Although there were 24
patients, there were 24 tibial insertions and 11 humeral
insertions on the same patient where clinically indicated for
a second peripheral access. The characteristics of the
patients are listed in Table 1.
All EZ-IO™ insertions were successful at the first
attempt except for three tibial insertions that were success-
ful on the second attempt. All insertions were firmly placed,
with good control of the needle set and separation from the
driver.
Table 2 shows a comparison between junior operators
(residents) and senior operators (attendings). Both groups
had 100% success rates for insertion. The average insertion
time was less than 5 s for both groups. In our study, the
VAS was 1.06. We noted that 88.6% of physicians in our
study reported easier insertion with the EZ-IO™ as
compared to an intravenous cannula.
The junior operators required more repeated attempts
and encountered low flow rates as compared to the senior
operators.
There were two complications encountered by a senior
operator. A glove was caught in the drill device during the
IO insertion. The physician had held the IO needle to
stabilize the needle’s position on the patient’s tibia while
applying the drill. As such, the glove was caught in the
needle and wound around the IO needle as the drill was
applied. Another complication encountered was extravasa-
tion of infusion fluid at the site of insertion of the IO
needle.
Table 3 shows the flow rates of intraosseous infusions
with and without pressure bag application. Flow rates were
significantly faster with a pressure bag than without. Tibial
flow rates were 204.6 ml/min with a pressure bag as
compared to 68.2 ml/min without a pressure bag, difference
−129.5 ml/min [95% confidence interval (CI): −218.2 to
−40.3). Humeral flow rates were significantly faster using a
pressure bag (148.1 ml/min) as compared to without
(81.8 ml/min), difference −69.6 ml/min (95% CI: −113.9 to
−25.3). But the difference of changes ( with or without
pressure bag) of flow rate between the tibia and humerus did
not show any significance (P = 0.157, Mann-Whitney test).
There were no complications of needle displacement,
failure of the drill device to function properly, fractures,
infection of the insertion site, osteomyelitis, fat embolism
or compartment syndrome.
Discussion
Available IO devices have included manual needles
including the Cook device and the Jamshidi needles,
spring-loaded “punch devices” including the First Access
for Shock and Trauma (F.A.S.T., Pyng) IO device in the
sternum [22] and the Bone Injection Gun (B.I.G) in the
tibia [23], which has been extensively used by the Israeli
military [24].
Preparation and insertion for the Pyng approaches 50 s
[22] with success rates of 74% for first time users and 95%
Table 1 EZ-IO: characteristics of study participants
N=24 %
Age 16–29 years 2 8.3
Age 30–59 years 6 25
Age > 60 years 16 66.7
Race
Chinese 17 70.8
Indian 4 16.7
Malay/others 3 12.5
Male 12 50
GCS 8–15 8 33.3
GCS 3–7 16 66.7
Trauma 4 16.7
Table 2 Comparison of intraosseous insertions between operators
Resident,
N=8 (%)
Attending/
consultant,
N=27 (%)
P value
EZ-IO placed successfully (%) 8 (100.0) 27 (100.0) 1
Multiple attempts needed (%) 2 (25) 1 (3.7) 0.083
Visual analogue scale (0–10) 1.1 1.0 0.920
EZ-IO firmly placed (%) 8 (100.0) 27 (100.0) 1
Good control of needle set (%) 8 (100.0) 27 (100.0) 1
Needle separated from driver
easily (%)
8 (100.0) 27 (100.0) 1
Stylet separated from needle
easily (%)
8 (100.0) 27 (100.0) 1
Easier placement with the EZ-IO
than an intravenous cannula (%)
8 (100.0) 23 (85.2) 0.553
No flow initially 1 (12.5) 0 1
Low flow rates 3 (37.5) 1 (2.9) 0.030
Complications 0 2 (5.7) 1
Insertion time (average), s 3.9 4.3 0.862
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patients with lower extremity or pelvic trauma [25]. The B.
I.G. is reported to require about 17 s for preparation and
insertion [26]. Preparation and insertion time for the EZ-IO
is reported to be approximately 10 s [27]. Prehospital trials
on the EZ-IO device show an 87% success rate. The F.A.S.
T.1 device used in the same trial showed 72% success [28].
In our hospital, the usual practice was to attempt
multiple peripheral IV insertions even though access may
be difficult or impossible. Central venous access is usually
not attempted, as it takes too long as compared to the
intraosseous method.
In our study, we had 100% success rates for both junior
and senior operators. Intraosseous flow rates were signifi-
cantly faster with a pressure bag infusion than without.
The IO needle had previously been shown to be a rapid
and effective method of vascular access [3, 4, 11, 13, 16,
19]. We found that even previously inexperienced operators
could rapidly and safely insert the IO needle. Previous
studies have also shown that emergency drugs and fluids
can be rapidly delivered to the systemic circulation, at rates
comparable to the intravenous and central venous routes
[28, 29]. All medications and blood products that are
approved for IV infusion can be given via an IO access. In
our study, the fluids and drugs used included normal saline,
dextrose, calcium chloride, atropine, epinephrine, frusemide
and ceftriaxone.
The maximum rate of administration through the IO
needle was reportedly equivalent to a 21 G peripheral
cannula [23]. The flow rates of an intravenous cannula are
typically in the range of 200 (16 G peripheral cannula) to
20 ml/min (24 G peripheral cannula) [30]. EZ-IO™ tibial
flow rates ranged from 20 to over 3,000 ml/h under
pressure [27].
In our study, we found that use of a pressure infusion
bag significantly improved fluid flow rates via the IO
needle. This is similar to a previous report using paediatric
IO needles [31], although we were able to achieve higher
flow rates using adult IO needles, hence subjectively able to
provide the necessary volume resuscitation in such circum-
stances. Pressure pumps improve flow of the IO needle.
Flushing of the IO needle after insertion seems to improve
flow rates as well [27].
Various site have been proposed as suitable for IO
insertions, including the proximal tibia [3, 4, 13], distal
tibia [2], sternum [4, 12, 13, 22], radius [32], clavicle [14],
proximal humerus and calcaneum [33]. The proximal tibia
and proximal humerus sites were chosen for this study. The
proximal tibia site was the initial insertion site of choice, as
the landmarks were easily identifiable, superficial, easy to
access percutaneously and proximal enough to allow rapid
access of fluids or medications into the central circulation.
In addition, it is away from vital areas where other
resuscitation procedures are ongoing as well as vital
structures that might get inadvertently punctured during
insertion. For example, the sternal and clavicular sites
present problems when airway procedures and cervical
immobilization are ongoing in trauma resuscitation. Like-
wise, the investigators felt that the distal tibia, radius and
calcaneum sites would be relatively distal to the central
circulation. The proximal humerus was the secondary site,
in the event that intravenous cannulation was still unsuc-
cessful after initial resuscitation.
Previously reported complications associated with IO
insertions include osteomyelitis [34], extravasation [35], fat
embolism [36], compartment syndrome [37], growth plate
abnormalities [38] and myonecrosis with hypertonic saline
infusion [39]. There were no reported complications with
the device in this study, except for two cases. One was
where the operator’s glove was caught in the IO drill device
during insertion. This could be easily prevented by not
holding the IO needle during the insertion process but just
allowing the drill to insert the IO needle.
Another complication was that of extravasation of fluid
at the site of insertion. Extravasation of fluid is the most
common complication [40]. It typically occurs when a
needle is misplaced. It seldom occurs with a properly
placed needle, and it is associated with excessive movement
during or after insertion, which may lead to enlargement of
the entry site in the bone relative to the diameter of the
needle. Compartment syndrome is a risk with extravasation
although our patient did not develop compartment syn-
drome. The needle must enter through the cortex and into
the marrow cavity without passing through the cortex on
the other side. If the needle is passed through the opposite
cortex, infused fluid enters the calf rather than the venous
system. Fluid accumulation may lead to a compartment
syndrome. This complication can also be limited by making
frequent checks and allowing only one attempt per tibia.
Repeated attempts in the same bone allow fluid to flow
Flow rate Tibia (N=10), ml/min Humerus (N=8), ml/min
No pressure bag 68.2 (42.1) 81.8 (38.4)
With pressure bag 204.6 (156.0) 148.1 (75.3)
Difference −129.5 −69.6
95% CI −218.2 to −40.3 −113.9 to −25.3
Table 3 Comparison of flow
rates with/without pressure
bag
P=0.157 (Mann-Whitney test)
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asation of hypertonic or caustic medications, such as
sodium bicarbonate, dopamine or calcium chloride, can
result in necrosis of the muscle.
There were two more cases where ward staff reported
difficulty removing the needle. However, the needles were
both successfully removed once the correct technique was
applied. The correct technique involves using a rotating and
pulling movement, rather than rocking the needle, which
may cause it to break. Also the needle comes with a Luer
lock which can be attached to a syringe to use as a handle
for additional traction during removal.
Limitations of the study include the relatively small
sample size. In many cases, subsequent intravenous
cannulation was successful, once initial resuscitation had
been initiated through the tibial IO access.
Also the insertion times were not recorded by an
independent observer due to the logistic difficulty of having
an investigator present at every resuscitation. We also noted
that insertion times may be longer in a true clinical setting,
as some time was required to assemble the driver and
needle. However, this time is minimal compared to the
actual insertion procedure.
The EZ-IO™ allowed medical personnel with little prior
experience of adult IO access to be able to achieve successful
placement in a fast mean. We also recommend routine use of
a pressure infusion bag in order to improve flow rates.
Conclusion
The EZ-IO™ is a feasible, useful and fast alternative mode of
venous access especially in the resuscitation of patients with
no venous access or when conventional intravenous access
fails.Flowrates may beimprovedbythe use ofpressurebags.
Complications encountered such as extravasation of fluid and
glovesbeingcaughtinthedrilldevicecanbeeasilyprevented.
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